
Image courtesy of Confer Health
Confer Health said today that it raised $9.5 million to support its development of affordable, at-home diagnostic devices featuring interchangeable cartridges, a reusable analyzer and a mobile app.
The Boston, Mass.-based company’s first urine-based diagnostic test is designed to help couples conceive by tracking three fertility hormones.
Get the full story at our sister site, Drug Delivery Business News.
With more than 30 speakers, 25 panels and 4 tracks, you can't miss DeviceTalks Minnesota![]() Join leaders from 3M, Abbott, Bigfoot Biomedical, Boston Scientific, Cardionomic, CMF Solutions, Cyient, Google Mayo Clinic, Medical Alley, Medtronic, NxThera, Opus College, Relievant Medsystems, University of Minnesota, Star Tribune, Smith & Nephew, Spry Health, Zimmer Biomet and many more when you register today. Use the code "DTWeb" to save 15% on the cost of registration. |
Leave a Reply
You must be logged in to post a comment.